Mitochondria — your 37-trillion-strong power grid

What mitochondria actually are

Mitochondria are microscopic organelles — about the size of a bacterium — sitting inside almost every cell you have. Their job is to convert the food you eat and the oxygen you breathe into ATP, the energy currency that powers literally every process in the body. A heart cell holds several thousand of them. A neuron, a liver cell, a fibroblast — all densely packed with these little engines.

When mitochondria are healthy, they're plentiful, they fuse and divide (a process called mitochondrial dynamics), and damaged ones get recycled through mitophagy. When they're stressed — by poor sleep, chronic inflammation, sedentary living, ultra-processed food — their numbers fall, their output drops, and the cell starts running on fumes. Scale that up to 37 trillion cells and you feel it as fatigue, brain fog, slower recovery, poorer skin and gradually, the thing we call aging.

Why decline feels like "getting old"

Mitochondrial density and function drop with age. Research in skeletal muscle and brain tissue shows measurable decline in respiratory chain capacity from roughly the fourth decade onward. Less ATP per cell means less energy for repair, less heat, less signalling, and slower clearance of cellular debris. It's not that the cells are worn out — it's that their power supply is.

The leverage point is that mitochondria respond to signals you can control: exercise, cold and heat exposure, fasting, and a small set of molecules that directly trigger the growth of new ones — a process called mitochondrial biogenesis.

PQQ — the biogenesis molecule

Pyrroloquinoline quinone (PQQ) is a small redox-active compound originally discovered as a bacterial growth factor. In cell-culture and rodent studies it activates the PGC-1α pathway (the master regulator of mitochondrial biogenesis). Human evidence is preliminary — small pilots, surrogate markers, no large RCTs. PPW treats PQQ as a comfort-tier adjunct, not a primary mitochondrial recommendation.

Key studies worth knowing:

• Chowanadisai et al., Journal of Biological Chemistry (2010) — showed that PQQ exposure increased mitochondrial content via CREB and PGC-1α activation in cultured mouse cells. This is the paper that put PQQ on the longevity map.
• Harris et al., Journal of Nutritional Biochemistry (2013) — human supplementation study (0.3 mg/kg) showed changes in urinary metabolites consistent with enhanced mitochondrial function and reduced inflammatory markers (CRP, IL-6).
• Nakano et al. (2012, 2022) — reported improvements in fatigue, sleep quality and cognitive markers in adults taking 20 mg PQQ daily over 8 weeks.

PQQ is not a stimulant — it's an adjunct with promising preclinical mechanism and limited human data. Inside the PPW stack, the proven levers do the heavy lifting: NMN raises blood NAD+ in human RCTs (Yi 2023, Yoshino 2021), CoQ10/Ubiquinol has stronger human evidence for heart-failure adjunct and statin-myopathy (Mortensen 2014, Banach 2015), and zone-2 cardio + cold + fasting are the proven biogenesis signals. PQQ sits alongside as a low-risk add-on, not the headline.

What else drives mitochondrial health

Supplements are downstream of signals. The upstream levers — and the ones I work on with clients first — are deceptively simple: zone-2 cardio two or three times a week (the single strongest biogenesis signal we know of), brief cold exposure, time-restricted eating, genuine deep sleep, and protein sufficiency. Add the stack on top of those and you compound. Take the stack without them and you waste your money.

The PQQ-led stack

Live multi-platform links. iHerb (10% off with code QCI0747) and Amazon UK (ppwellness21-21). Pick your region and click.